RXST today
$5.32-$0.06 (-1.12%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns down below $4.75
Key levels
Resistance$6.66
Resistance$6.05
Support$5.19
Support$4.75
Latest news & SEC filings
AnalystNeedham trims RxSight target to $7, maintains Buy rating
AnalystWells Fargo trims RxSight price target, now $6.00 versus $9.00
AnalystPiper Sandler keeps Neutral rating on RxSight, cuts target to $8
All RXST news →About RxSight
RxSight makes a system for tailoring eyesight following cataract removal. The offering includes an adjustable intraocular lens, a device that emits light to modify it, and supporting accessories, letting surgeons fine-tune results after implantation. Its customers are cataract surgeons and eye care practices, mainly in the United States.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
RxSight, Inc. (RXST)
What Is the Price Target for RXST?
SEPT Low Target
$5.50
SEPT Mid Target
$6.65
SEPT High Target
$8.00
Analyst Consensus
$6.65
Is RXST a Buy or Sell Right Now?
Thesis
- •Revenue growing -3.9% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RXST.
Start Free Trial →Is RXST Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$8.98
43
Moat Score
NARROW
3/9
Piotroski Score
1.1
Altman Z-Score
What Is Smart Money Doing with RXST?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kurtz Ronald M MD | officer | Sale | 5,100 | $35K | Sep 2, 2026 |
| Wilterding Mark | officer | Sale | 7,765 | $54K | Sep 2, 2026 |
| Goldshleger Ilya | officer | Sale | 2,041 | $14K | Sep 2, 2026 |
| Weinberg Eric | officer | Sale | 2,041 | $14K | Sep 2, 2026 |
| Kurtz Ronald M MD | officer | Buy | 13,425 | - | Aug 31, 2026 |
| Wilterding Mark | officer | Buy | 20,441 | - | Aug 31, 2026 |
| Goldshleger Ilya | officer | Buy | 5,370 | - | Aug 31, 2026 |
| Weinberg Eric | officer | Buy | 5,370 | - | Aug 31, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RXST Growth Story
Revenue YoY
-3.9%
3yr Revenue CAGR
40.0%
EPS Growth YoY
-33.8%
FCF Growth YoY
13.6%
Revenue Trend
STRONG
Dark Pool Trades for RXST
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RXST, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:37 | $5.32 | 5,900 | $$31K | SELL |
| 20:54:44 | $5.34 | 1,000 | $$5K | MIDPOINT |
| 20:50:20 | $5.36 | 1,000 | $$5K | SELL |
| 20:38:31 | $5.39 | 1,048 | $$6K | BUY |
| 20:36:53 | $5.30 | 1,000 | $$5K | SELL |
5 dark pool trades shown · $$53K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for RXST
PREVIEWSEPT Investing provides real-time options flow tracking for RXST, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $5 | Mar 19 | 126 | $$140 | 2 | SWEEP |
| PUT | $5 | Mar 19 | 126 | $$140 | 2 | SWEEP |
| PUT | $5 | Mar 19 | 126 | $$140 | 2 | SWEEP |
| PUT | $5 | Mar 19 | 126 | $$1260 | 18 | SWEEP |
| PUT | $5 | Mar 19 | 126 | $$140 | 2 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for RxSight, Inc. (RXST) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RXST — frequently asked questions
What is RXST stock price today?
RxSight, Inc. (RXST) is at $5.32, down 1.12% (-$0.06) at the Nov 13, 2026 close.
Why is RXST stock moving today?
Latest RXST news — Nov 5, 2026: Needham trims RxSight target to $7, maintains Buy rating · Nov 5, 2026: Wells Fargo trims RxSight price target, now $6.00 versus $9.00
What is the RXST price target?
The average analyst price target for RXST is $6.65, ranging from $6 to $8, based on 6 analysts. Latest: Wells Fargo maintains on Nov 4, 2026.
What do analysts rate RXST?
Analyst ratings for RXST: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did RXST beat earnings?
RXST last reported on Nov 3, 2026: EPS -$0.21 vs -$0.31 expected — a beat of 31.5%.
Does RXST pay a dividend?
RXST does not currently pay a dividend.
What are RXST support and resistance levels?
Support: $5.19, $4.75, $4.11. Resistance: $6.05, $6.66, $7.02.
What are insiders doing with RXST?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on RXST?
Nov 5, 2026: Needham trims RxSight target to $7, maintains Buy rating · Nov 5, 2026: Wells Fargo trims RxSight price target, now $6.00 versus $9.00 · Nov 4, 2026: Piper Sandler keeps Neutral rating on RxSight, cuts target to $8